216 related articles for article (PubMed ID: 20537544)
21. Discovery of allosteric inhibitors of kinesin spindle protein (KSP) for the treatment of taxane-refractory cancer: MK-0731 and analogs.
Cox CD; Garbaccio RM
Anticancer Agents Med Chem; 2010 Nov; 10(9):697-712. PubMed ID: 21235439
[TBL] [Abstract][Full Text] [Related]
22. Kinesin spindle protein (KSP) inhibitors with 2,3-fused indole scaffolds.
Oishi S; Watanabe T; Sawada J; Asai A; Ohno H; Fujii N
J Med Chem; 2010 Jul; 53(13):5054-8. PubMed ID: 20521839
[TBL] [Abstract][Full Text] [Related]
23. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
[TBL] [Abstract][Full Text] [Related]
24. Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.
Matsuno K; Sawada J; Sugimoto M; Ogo N; Asai A
Bioorg Med Chem Lett; 2009 Feb; 19(4):1058-61. PubMed ID: 19167222
[TBL] [Abstract][Full Text] [Related]
25. Structure-based design of new KSP-Eg5 inhibitors assisted by a targeted multicomponent reaction.
Carbajales C; Prado MÁ; Gutiérrez-de-Terán H; Cores A; Azuaje J; Novio S; Nuñez MJ; Fernández-García B; Sotelo E; García-Mera X; Sánchez-Lazo P; Freire-Garabal M; Coelho A
Chembiochem; 2014 Jul; 15(10):1471-80. PubMed ID: 24943831
[TBL] [Abstract][Full Text] [Related]
26. Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.
Fraley ME; Garbaccio RM; Arrington KL; Hoffman WF; Tasber ES; Coleman PJ; Buser CA; Walsh ES; Hamilton K; Fernandes C; Schaber MD; Lobell RB; Tao W; South VJ; Yan Y; Kuo LC; Prueksaritanont T; Shu C; Torrent M; Heimbrook DC; Kohl NE; Huber HE; Hartman GD
Bioorg Med Chem Lett; 2006 Apr; 16(7):1775-9. PubMed ID: 16439123
[TBL] [Abstract][Full Text] [Related]
27. The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5.
Schiemann K; Finsinger D; Zenke F; Amendt C; Knöchel T; Bruge D; Buchstaller HP; Emde U; Stähle W; Anzali S
Bioorg Med Chem Lett; 2010 Mar; 20(5):1491-5. PubMed ID: 20149654
[TBL] [Abstract][Full Text] [Related]
28. Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP.
Knight SD; Parrish CA
Curr Top Med Chem; 2008; 8(10):888-904. PubMed ID: 18673173
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of biphenyl compounds as kinesin spindle protein inhibitors.
Holland JP; Kang A; Cohrs S; Selivanova SV; Milicevic Sephton S; Betzel T; Frey D; Wieser M; Jaussi R; Kammerer RA; Schibli R; Fischer E
Chem Biodivers; 2013 Apr; 10(4):538-55. PubMed ID: 23576341
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Structure-Activity Relationships of Tetrahydro-β-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents.
Zhang M; Park EJ; Kondratyuk TP; Pezzuto JM; Sun D
Anticancer Res; 2018 Aug; 38(8):4425-4433. PubMed ID: 30061206
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
Chen Z; Cao R; Shi B; Guo L; Sun J; Ma Q; Fan W; Song H
Eur J Med Chem; 2011 Oct; 46(10):5127-37. PubMed ID: 21875764
[TBL] [Abstract][Full Text] [Related]
33. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.
Tao W; South VJ; Diehl RE; Davide JP; Sepp-Lorenzino L; Fraley ME; Arrington KL; Lobell RB
Mol Cell Biol; 2007 Jan; 27(2):689-98. PubMed ID: 17101792
[TBL] [Abstract][Full Text] [Related]
34. Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffolds.
Zhao GD; Wan RZ; Liu ZP
Curr Med Chem; 2014; 21(23):2691-701. PubMed ID: 24606497
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β signaling pathway.
Zheng C; Fang Y; Tong W; Li G; Wu H; Zhou W; Lin Q; Yang F; Yang Z; Wang P; Peng Y; Pang X; Yi Z; Luo J; Liu M; Chen Y
J Med Chem; 2014 Feb; 57(3):600-12. PubMed ID: 24417479
[TBL] [Abstract][Full Text] [Related]
36. Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP.
Garbaccio RM; Tasber ES; Neilson LA; Coleman PJ; Fraley ME; Olson C; Bergman J; Torrent M; Buser CA; Rickert K; Walsh ES; Hamilton K; Lobell RB; Tao W; South VJ; Diehl RE; Davide JP; Yan Y; Kuo LC; Li C; Prueksaritanont T; Fernandez-Metzler C; Mahan EA; Slaughter DE; Salata JJ; Kohl NE; Huber HE; Hartman GD
Bioorg Med Chem Lett; 2007 Oct; 17(20):5671-6. PubMed ID: 17804233
[TBL] [Abstract][Full Text] [Related]
37. Targeting the kinesin spindle protein: basic principles and clinical implications.
Sarli V; Giannis A
Clin Cancer Res; 2008 Dec; 14(23):7583-7. PubMed ID: 19047082
[TBL] [Abstract][Full Text] [Related]
38. New 3-tetrazolyl-β-carbolines and β-carboline-3-carboxylates with anti-cancer activity.
Panice MR; Lopes SMM; Figueiredo MC; Goes Ruiz ALT; Foglio MA; Nazari Formagio AS; Sarragiotto MH; Pinho E Melo TMVD
Eur J Med Chem; 2019 Oct; 179():123-132. PubMed ID: 31247374
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of inhibition of human KSP by ispinesib.
Lad L; Luo L; Carson JD; Wood KW; Hartman JJ; Copeland RA; Sakowicz R
Biochemistry; 2008 Mar; 47(11):3576-85. PubMed ID: 18290633
[TBL] [Abstract][Full Text] [Related]
40. Discovery of 4-anilino α-carbolines as novel Brk inhibitors.
Mahmoud KA; Krug M; Wersig T; Slynko I; Schächtele C; Totzke F; Sippl W; Hilgeroth A
Bioorg Med Chem Lett; 2014 Apr; 24(8):1948-51. PubMed ID: 24650640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]